At the time of writing, Veracyte Inc [VCYT] stock is trading at $45.64, up 4.61%. An important factor to consider is whether the stock is rising or falling in short-term value. The VCYT shares have gain 6.44% over the last week, with a monthly amount drifted -3.73%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Canaccord Genuity started tracking the stock with Hold rating on October 20, 2025, and set its price target to $40. On March 20, 2025, Craig Hallum initiated with a Buy rating and assigned a price target of $45 on the stock. Goldman downgraded its rating to a Neutral and decreased its price target to $37 on December 05, 2024. Wolfe Research initiated its recommendation with an Outperform and recommended $50 as its price target on November 15, 2024. UBS started tracking with a Buy rating for this stock on October 16, 2024, and assigned it a price target of $43. In a note dated October 10, 2024, Guggenheim initiated a Buy rating and provided a target price of $40 on this stock.
For the past year, the stock price of Veracyte Inc fluctuated between $22.61 and $50.71. Currently, Wall Street analysts expect the stock to reach $47.25 within the next 12 months. Veracyte Inc [NASDAQ: VCYT] shares were valued at $45.64 at the most recent close of the market. An investor can expect a potential return of 3.53% based on the average VCYT price forecast.
Analyzing the VCYT fundamentals
According to Veracyte Inc [NASDAQ:VCYT], the company’s sales were 495.14M for trailing twelve months, which represents an 13.82% jump. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.03 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 44.11 points at the first support level, and at 42.59 for the second support level. However, for the 1st resistance point, the stock is sitting at 46.46, and for the 2nd resistance point, it is at 47.29.
Ratios To Look Out For
It is important to note that Veracyte Inc [NASDAQ:VCYT] has a current ratio of 6.23. On the other hand, the Quick Ratio is 5.94, and the Cash Ratio is 4.37. Considering the valuation of this stock, the price to sales ratio is 7.29, the price to book ratio is 2.87 and price to earnings (TTM) ratio is 120.20.
Transactions by insiders
Recent insider trading involved McGuire Annie, SVP, General Counsel, that happened on Dec 16 ’25 when 10739.0 shares were sold. Officer, ANN MCGUIRE completed a deal on Dec 16 ’25 to buy 10739.0 shares. Meanwhile, Director EASTHAM KARIN sold 20000.0 shares on Dec 05 ’25.
